Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Egis Pharmaceuticals PLC

    Client Virtual Booth

    EGIS PHARMACEUTICALS PLC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    Key Products KEY PRODUCTS

    • Abemaciclib

    • Atorvastatin

    • Chlorpromazine Hydrochloride

    • Levomepromazine Maleate

    • Osimertinib Mesylate

    • Pregabalin

    • Promethazine Hydrochloride

    • Ramipril

    • Ribociclib

    • Sacubitril-Valsartan

    SERVICES

    Key Products KEY SERVICES

    • CDMO for Small Molecules

    • Dev. & Manufacturing of Intermediates & APIs

    • Contract Mfg. for Intermediates & APIs

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Egis Pharmaceuticals
    Egis Pharmaceuticals PLC
    Hungary Flag
    Country
    Country
    Hungary
    Address
    Address
    1106 Budapest, Keresztúri út 30-38
    Telephone
    Telephone
    +36 18035555
    Client Email
    Email
    mailbox@egis.hu
    Client Website
    Website
    https://int.egis.health/home
    Linkedin
    Linkedin
    https://www.linkedin.com/company/egis-pharmaceuticals-plc/
    Twitter
    Twitter
    Contact Info
    Others

    FDFs
    fpd.opr@egis.hu
    APIs
    bulk.opr@egis.hu
    Services:
    pharmaservices@egis.hu

    Full View ScreenFull Screen View
    Hungarian Pharmaceutical Company Debuts New Services in Barcelona
    Hungarian Pharmaceutical Company Debuts New Services in Barcelona

    https://hungarytoday.hu/hungarian-pharmaceutical-company-debuts-new-services-in-barcelona/

    HUNGARY TODAY
    25 Oct 2023
    Share Share
    Egis expands its portfolio with active pharmaceutical ingredient contract development and contract manufacturing
    Egis expands its portfolio with active pharmaceutical ingredient contract development and contract manufacturing

    https://int.egis.health/a/en-yfddg

    PRESS RELEASE
    24 Oct 2023
    Share Share
    Suprastin Becomes Georgian Consumers’ Favorite Allergy Remedy
    Suprastin Becomes Georgian Consumers’ Favorite Allergy Remedy

    https://finchannel.com/suprastin-becomes-georgian-consumers-favorite-allergy-remedy/116293/golden-brand-annual-award-ceremony/2023/06/

    FINCHANNEL
    25 Jun 2023
    Share Share
    Egis sponsored the 40th Hungarian Press Photo Contest
    Egis sponsored the 40th Hungarian Press Photo Contest

    https://int.egis.health/a/egis-sponsored-the-hungarian-press-photo-contest

    PRESS RELEASE
    04 May 2022
    Share Share
    Egis Pharma has relocated its main offices at One Tower building
    Egis Pharma has relocated its main offices at One Tower building

    https://business-review.eu/business/pharmaceuticals/egis-pharmaceuticals-has-relocated-its-main-offices-at-one-tower-building-227098

    BUSINESS REVIEW
    25 Jan 2022
    Share Share
    Egis Favipiravir Drug Licenced for Covid-19 Treatment
    Egis Favipiravir Drug Licenced for Covid-19 Treatment

    https://hungarytoday.hu/coronavirus-egis-favipiravir-drug-licenced-covid-19-treatment/

    HUNGARYTODAY
    20 Dec 2021
    Share Share
    Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharma
    Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharma

    https://www.businesswire.com/news/home/20211213005486/en/Crescita-Signs-Exclusive-8-Cou[%E2%80%A6]ing-Agreement-with-Egis-Pharmaceuticals-for-Pliaglis%C2%AE

    BUSINESSWIRE
    13 Dec 2021
    Share Share
    Egis Group to invest €50 million in India over the next five years
    Egis Group to invest €50 million in India over the next five years

    https://economictimes.indiatimes.com/industry/services/property-/-cstruction/egis-group-to-invest-50-million-in-india-over-the-next-five-years/articleshow/87651487.cms

    ECONOMIC TIMES
    11 Nov 2021
    Share Share
    Genedata has Successfully Collaborated with Egis Pharmaceuticals PLC
    Genedata has Successfully Collaborated with Egis Pharmaceuticals PLC

    https://int.egis.health/cps/press-release-genedata-has-successfully-collaborated-with-egis-pharmaceuticals-plc-to-develop-a-pre

    PRESS RELEASE
    12 Oct 2021
    Share Share
    Egis Pharma Registers First Blood-based CE IVD Precision Medicine Tool
    Egis Pharma Registers First Blood-based CE IVD Precision Medicine Tool

    https://www.medindia.net/health-press-release/Egis-Pharmaceuticals-PLC-Announces-Regi[%E2%80%A6]ecision-Medicine-Tool-for-Therapy-Selection-in--516488-1.htm

    MEDINDIA
    16 Mar 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Egis Pharmaceuticals

    euroPLX Dublin

    Attending

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search